Baolingbao Biology Co.,Ltd. (SHE:002286)
9.79
-0.07 (-0.71%)
Oct 31, 2025, 3:04 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.73 billion as of October 31, 2025. Its market cap has increased by 50.84% in one year.
Market Cap
3.73B
Enterprise Value
3.65B
Revenue
2.69B
Ranking
n/a
PE Ratio
25.07
Stock Price
9.79
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.73B, an increase of 106.23%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 3.75B | 37.51% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | 4.21B | 89.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.50B |
| WuXi AppTec | 288.71B |
| Shenzhen Mindray Bio-Medical Electronics | 269.49B |
| Sichuan Biokin Pharmaceutical | 141.91B |
| Shanghai United Imaging Healthcare | 115.65B |
| Aier Eye Hospital Group | 113.13B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.79B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |